Status:
RECRUITING
Study on the Diagnosis and Management of CLL in Italy by GIMEMA
Lead Sponsor:
Gruppo Italiano Malattie EMatologiche dell'Adulto
Conditions:
Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma
Eligibility:
All Genders
18+ years
Brief Summary
retrospective and prospective multicenter observational clinical and biological data collection from all patients with newly diagnosed CLL, SLL or MBL. retrospective cohort: all cases with a diagnosi...
Detailed Description
This is a retrospective and prospective multicenter observational study designed by the Gruppo Italiano Malattie EMatologiche dell'Adulto (GIMEMA). The study consists of clinical and biological data c...
Eligibility Criteria
Inclusion
- Age ≥18 years at diagnosis
- One of the following diagnoses that meet the international diagnostic criteria (iwCLL2018 and WHO2017)
- Chronic lymphocytic leukemia (CLL)
- Small lymphocytic lymphoma (SLL)
- CLL-like monoclonal B-cell lymphocytosis (MBL)
- Retrospective cohort: CLL/SLL/MBL diagnosis between January 1st 2010 and August 31th 2021.
- Prospective cohort: CLL/SLL/MBL diagnosis between September 1st 2021 and September 1st, 2025.
- Signed written informed consent according to ICH/EU/GCP and national local laws (if applicable)
Exclusion
- \- -
Key Trial Info
Start Date :
October 13 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
12500 Patients enrolled
Trial Details
Trial ID
NCT04867915
Start Date
October 13 2021
End Date
October 1 2026
Last Update
March 14 2025
Active Locations (24)
Enter a location and click search to find clinical trials sorted by distance.
1
Aon Ss. Antonio E Biagio E C. Arrigo - Alessandria - Soc Ematologia
Alessandria, Italy
2
Asst Degli Spedali Civili Di Brescia - Ssvd Centro Trapianti Midollo Per Adulti - Cattedra Di Ematologia
Brescia, Italy
3
Asl Brindisi, Ospedale 'Perrino' - Brindisi - Uo Ematologia
Brindisi, Italy
4
Fondazione Del Piemonte Per L'Oncologia Centro Trapianti
Candiolo, Italy